Prescription drug · ANDA
Prazosin hydrochloride NDC 70518-4263
Prazosin hydrochloride 2 mg/1 · Capsule · Oral · REMEDYREPACK INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70518-4263-0 | 70518426300 | 30 CAPSULE in 1 BLISTER PACK (70518-4263-0)Marketed from Jan 23, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Prazosin hydrochloride
- Generic name (nonproprietary)
- prazosin hydrochloride
- Active ingredients
- Prazosin hydrochloride — 2 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- REMEDYREPACK INC.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 213406
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Antagonists (Mechanism)
- Identifiers
- Product ID 70518-4263_5a7fd9ea-80ac-e86f-e063-6294a90a7715SPL ID 5a7fd9ea-80ac-e86f-e063-6294a90a7715SPL set ID b55790fa-2413-4243-83ec-0391b2effe11RxCUI 312594UNII X0Z7454B90
- Pharmacologic class
- alpha-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470518426300followed by a unit qualifier and the quantityPackage 70518-4263-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Prazosin hydrochloride capsules is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve bl…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 213406
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Prazosin hydrochloride | Prazosin hydrochloride 2 mg/1 | CapsuleOral | Biocon Pharma Inc. | 70377-067 |
| Prazosin hydrochloride | Prazosin hydrochloride 1 mg/1 | CapsuleOral | Biocon Pharma Inc. | 70377-066 |
| Prazosin hydrochloride | Prazosin hydrochloride 5 mg/1 | CapsuleOral | Biocon Pharma Inc. | 70377-068 |
| Prazosin hydrochloride | Prazosin hydrochloride 1 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-3928 |